75 5. ASSESSMENT › 5.1. Existence of aid › (a) The risk shield and capital contribution measures (first three measures), Decision_act (EU) 2009/775

In forcesince 21 Oct 2008

The same applies to the second measure, which, according to information supplied by Germany, was a mere ancillary to the first risk shield. Thus, even if the participations of KfW and the banking associations seem more balanced in absolute terms (in relative terms the participation of the banking associations should still be much higher) this measure must be seen together with the first measure in the overall restructuring context, and settled case-law bars KfW from reverting to the market-economy investor argument after it has not acted as a market investor [In Case T-11/95 BP Chemicals [1998] ECR II-3235 it was held that the mere fact that a public undertaking has already made capital injections into a subsidiary which are classed as ‘aid’ does mean that a further capital injection cannot easily be classed as an investment which satisfies the private market-economy investor test, in particular if it cannot reasonably be separated from these first injections and classed as an independent investment. The Court considers that the chronology of the capital injections, their purpose and the subsidiary’s situation at the time when each decision to make an injection was made are relevant factors for such a determination.].

  • Judgment of the Court of First Instance (Second Chamber, extended composition) of 15 September 1998. BP Chemicals Limited v Commission of thDecision

    15 Sep 1998 · 61995TJ0011